Cancers 2021, 13(3), 558; https://doi.org/10.3390/cancers13030558 - 01 Feb 2021
Best Paper Award
Dear Colleagues,
The editorial team would like to congratulate the winners of the Cancers 2020 Best Paper Award, who were chosen by a selection committee chaired by the Editor-in-Chief, Prof. Dr. Samuel C. Mok. Following a review process by the Award Evaluation Committee, four winners were selected.
Article:
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
By Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof and Rosa Legood
Cancers 2020, 12(7), 1929; doi: 10.3390/cancers12071929
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
By Aimy Sebastian, Nicholas R. Hum, Kelly A. Martin, Sean F. Gilmore, Ivana Peran, Stephen W. Byers, Elizabeth K. Wheeler, Matthew A. Coleman and Gabriela G. Loots
Cancers 2020, 12(5), 1307; doi: 10.3390/cancers12051307
Review:
Ferroptosis in Cancer Cell Biology
By Christina M. Bebber, Fabienne Müller, Laura Prieto Clemente, Josephine Weber and Silvia von Karstedt
Cancers 2020, 12(1), 164; doi: 10.3390/cancers12010164
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
By Raju K. Vaddepally, Prakash Kharel, Ramesh Pandey, Rohan Garje and Abhinav B. Chandra
Cancers 2020, 12(3), 738; doi: 10.3390/cancers12030738
Each winner (corresponding author) will receive CHF 500, a chance to publish a paper free of charge in Cancers in 2022 after the normal peer-review procedure, and an electronic certificate.
Please join us in congratulating the winners of the Cancers 2020 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Cancers.
Kind regards,
Cancers Editorial Office
Cancers 2020 Best Paper Award
Past Winners
Year:
Winner
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
STING Agonists as Cancer Therapeutics
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695 - 30 May 2021
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112 - 27 Apr 2021
Winner
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
Cancers 2022, 14(14), 3341; https://doi.org/10.3390/cancers14143341 - 09 Jul 2022
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627 - 26 Jan 2022
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Cancers 2022, 14(9), 2266; https://doi.org/10.3390/cancers14092266 - 01 May 2022
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Prof. Donat Kögel
Klinikum der Goethe-Universität Frankfurt
Dr. Nicola Amodio
Università Magna Graecia di Catanzaro
Winner
John Maher
King’s College London, School of Cancer and Pharmaceutical Studies, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK
https://www.mdpi.com/2072-6694/11/5/674
Barbara Wegiel
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
https://www.mdpi.com/2072-6694/11/4/450
Massimo Libra
Department of Biomedical and Biotechnological Sciences, Oncologic, Clinic and General Pathology Section, University of Catania, 95123 Catania, Italy
https://www.mdpi.com/2072-6694/11/1/38
Anthony Gonçalves
Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France
https://www.mdpi.com/2072-6694/11/7/1033
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
